Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 27;10(13):2838.
doi: 10.3390/jcm10132838.

Diagnostic Potential of Low Serum Platelet, Albumin and Prolong PT-INR for Overactive Bladder and Nocturia in Chronic Hepatitis-Related Liver Cirrhosis

Po-Heng Chuang  1 , Yi-Huei Chang  2 , Po-Jen Hsiao  2 , Eric Chieh-Lung Chou  2
Affiliations

Diagnostic Potential of Low Serum Platelet, Albumin and Prolong PT-INR for Overactive Bladder and Nocturia in Chronic Hepatitis-Related Liver Cirrhosis

Po-Heng Chuang et al. J Clin Med. .

Abstract

Overactive bladder (OAB) is defined as urgency, usually with frequency, nocturia, and incontinence. Patients with liver cirrhosis often present with urinary complaints. The possible reason for this is fluid redistribution, which may induce OAB resulting from portal hypertension and ascites. We conducted this study to investigate predictors of OAB in cirrhotic patients. A total of 164 patients with chronic viral hepatitis-related liver cirrhosis were enrolled and 158 (96.3%) completed the Overactive Bladder Symptoms Score (OABSS) questionnaire. Age, severity of liver cirrhosis, comorbidities, serum sodium level, use of diuretics, body mass index and renal function were also recorded. In the study cohort, the prevalence of OAB was 31.01% and the prevalence of urge incontinence (OAB wet) was 18.3%. Patients with an urgency score ≥2 in OABSS had a significantly lower platelet level (p = 0.025) regardless of the use of diuretics. In addition, 98 patients (62%) with nocturia and 29 patients (18%) with urge incontinence had significantly lower levels of serum albumin (p = 0.028 and 0.044, respectively). In conclusion, patients with liver cirrhosis have a high prevalence of overactive bladder. A low platelet and low serum albumin level in these patients may be predictors for overactive bladder. And longer PT-INR is also a possible biomarker for nocturia.

Keywords: frequency; incontinence; liver cirrhosis; nocturia; overactive bladder; urgency.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Sepanlou S.G., Safiri S., Bisignano C., Ikuta K.S., Merat S., Saberifiroozi M., Poustchi H., Tsoi D., Colombara D.V., Abdoli A., et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 2020;5:245–266. doi: 10.1016/S2468-1253(19)30349-8. - DOI - PMC - PubMed
    1. Tsochatzis E., Bosch J., Burroughs A.K. Liver cirrhosis. Lancet. 2014;383:1749–1761. doi: 10.1016/S0140-6736(14)60121-5. - DOI - PubMed
    1. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., Van Kerrebroeck P., Victor A., Wein A. The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49. doi: 10.1016/S0090-4295(02)02243-4. - DOI - PubMed
    1. Griebling T.L. Worldwide Prevalence Estimates of Lower Urinary Tract Symptoms, Overactive Bladder, Urinary Incontinence, and Bladder Outlet Obstruction. BJU Int. 2011;108:1138–1139. doi: 10.1111/j.1464-410X.2011.10498.x. - DOI - PubMed
    1. Irwin D.E., Milsom I., Kopp Z., Abrams P., Artibani W., Herschorn S. Prevalence, Severity, and Symptom Bother of Lower Urinary Tract Symptoms among Men in the EPIC Study: Impact of Overactive Bladder. Eur. Urol. 2009;56:14–20. doi: 10.1016/j.eururo.2009.02.026. - DOI - PubMed

LinkOut - more resources